J. Wiebe

发表

A new novolimus-eluting bioresorbable coronary scaffold: Present status and future clinical perspectives.

C. Hamm, N. Foin, H. Nef, 2017, International journal of cardiology.

Bioresorbable scaffold implantation in patients with indication for oral anticoagulation: A propensity matched analysis.

C. Hamm, H. Möllmann, A. Elsässer, 2017, International journal of cardiology.

Long-Term Clinical Outcomes of Patients Treated With Everolimus-Eluting Bioresorbable Stents in Routine Practice: 2-Year Results of the ISAR-ABSORB Registry.

H. Schunkert, M. Joner, A. Kastrati, 2017, JACC. Cardiovascular interventions.

Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease: A Matched Comparison.

A. Kastrati, C. Hamm, C. Liebetrau, 2017, JACC. Cardiovascular interventions.

Angiographic and clinical outcomes of patients treated with everolimus‐eluting bioresorbable stents in routine clinical practice: Results of the ISAR‐ABSORB registry

H. Schunkert, M. Joner, A. Kastrati, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Drug-Eluting Balloons or Stents for Bare-Metal Stent Restenosis.

A. Kastrati, R. Colleran, J. Wiebe, 2016, JACC. Cardiovascular interventions.

Impact of the learning curve on procedural results and acute outcome after percutaneous coronary interventions with everolimus-eluting bioresorbable scaffolds in an all-comers population.

S. Achenbach, C. Hamm, C. Liebetrau, 2015, Cardiovascular revascularization medicine : including molecular interventions.

Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) trial

H. Schunkert, M. Joner, A. Kastrati, 2018, European heart journal.

First-in-Man Coronary Sinus Lead Stabilization Using a Bioresorbable Vascular Scaffold System.

C. Hamm, D. Erkapic, J. Schmitt, 2015, Circulation. Arrhythmia and electrophysiology.

Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosis

H. Schunkert, M. Joner, A. Kastrati, 2022, Clinical Research in Cardiology.

Angiographic performance of everolimus‐eluting stents for the treatment of coronary in‐stent restenosis in daily practice

H. Schunkert, M. Joner, A. Kastrati, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Everolimus- vs. novolimus-eluting bioresorbable scaffolds in patients with acute coronary syndrome

C. Hamm, C. Liebetrau, H. Möllmann, 2019, Herz.

1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.

J. Mehilli, C. Di Mario, A. Colombo, 2016, JACC. Cardiovascular interventions.

Brain-derived neurotrophic factor as a marker for immediate assessment of the success of renal sympathetic denervation.

C. Hamm, C. Liebetrau, L. Gaede, 2015, Journal of the American College of Cardiology.

Prognostic value of haemoglobin drop in patients with acute coronary syndromes

H. Schunkert, M. Joner, A. Kastrati, 2021, European journal of clinical investigation.

Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST Registry.

L. Räber, J. Wykrzykowska, S. Windecker, 2017, Journal of the American College of Cardiology.

Very late scaffold thrombosis after everolimus-eluting bioresorbable scaffold implantation in patients with unremarkable interim surveillance angiography.

M. Joner, A. Kastrati, R. Colleran, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Everolimus-eluting bioresorbable scaffold implantation for the treatment of bifurcation lesions - Implications from early clinical experience during daily practice.

C. Hamm, C. Liebetrau, H. Möllmann, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry.

J. Mehilli, C. Di Mario, A. Colombo, 2017, JACC. Cardiovascular interventions.

Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST‐EU Registry

J. Mehilli, C. Di Mario, A. Colombo, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Hemodynamic structural valve deterioration following transcatheter aortic valve implantation with latest-generation balloon-expandable valves.

C. Hengstenberg, H. Schunkert, M. Joner, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Percutaneous mitral valve repair with the mitraclip system according to the predicted risk by the logistic EuroSCORE: Preliminary results from the German Transcatheter Mitral Valve Interventions (TRAMI) registry

K. Kuck, P. Boekstegers, H. Eggebrecht, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry.

J. Mehilli, C. Di Mario, A. Colombo, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Outcomes of 10,312 patients treated with everolimus‐eluting bioresorbable scaffolds during daily clinical practice – results from the European Absorb Consortium

S. Achenbach, A. Baumbach, A. Zaman, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Five‐year follow‐up of patients who underwent everolimus‐eluting bioresorbable scaffold implantation

S. Achenbach, C. Hamm, C. Liebetrau, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Long-term follow-up and predictors of target lesion failure after implantation of everolimus-eluting bioresorbable scaffolds in real-world practice.

A. Kastrati, J. Mehilli, C. Hamm, 2020, International Journal of Cardiology.

Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R).

S. Achenbach, A. Schmermund, J. Mehilli, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry.

J. Mehilli, C. Di Mario, A. Colombo, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry.

H. Schunkert, A. Kastrati, Y. Harada, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Mechanisms of Very Late Bioresorbable Scaffold Thrombosis

L. Räber, J. Wykrzykowska, S. Windecker, 2022 .

Prevalence and Clinical Impact of Iron Deficiency in Patients With Severe Aortic Stenosis Referred for Transcatheter Aortic Valve Implantation.

C. Hengstenberg, H. Schunkert, M. Joner, 2019, The American journal of cardiology.

Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosis

H. Schunkert, M. Joner, A. Kastrati, 2022, Clinical Research in Cardiology.

Long-Term Prognostic Impact of Restenosis of the Unprotected Left Main Coronary Artery Requiring Repeat Revascularization.

H. Schunkert, A. Kastrati, J. Mehilli, 2020, JACC. Cardiovascular interventions.

Five‐year follow‐up of polymer‐free sirolimus‐ and probucol‐eluting stents versus new generation zotarolimus‐eluting stents in patients presenting with st‐elevation myocardial infarction

A. Kastrati, Y. Harada, Raphaela Lohaus, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

A prospective trial of a novel low‐dose paclitaxel‐coated balloon therapy in patients with restenosis in drug‐eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In‐stent REstenosis 3A (ISAR‐DESIRE 3A)

H. Schunkert, M. Joner, A. Kastrati, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

“Full bioresorbable jacket”

C. Hamm, C. Liebetrau, H. Möllmann, 2015, Herz.

Current status of bioresorbable scaffolds in the treatment of coronary artery disease.

C. Hamm, H. Nef, J. Wiebe, 2014, Journal of the American College of Cardiology.

Bioresorbable scaffolds in daily clinical routine: a practical review of all-comers results

C. Hamm, H. Nef, J. Wiebe, 2015, Current opinion in cardiology.

Target and non-target vessel related events at 10 years post percutaneous coronary intervention

H. Schunkert, M. Joner, A. Kastrati, 2022, Clinical Research in Cardiology.

Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects

S. Achenbach, C. Hamm, C. Schlundt, 2017, Clinical Research in Cardiology.

A true bifurcational stenosis treated with a bioresorbable vascular scaffold and a drug‐eluting metallic stent: Degradable meets durable

C. Hamm, H. Nef, J. Wiebe, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

OP-EHEA180727 167..176

H. Schunkert, M. Joner, A. Kastrati, 2019 .

Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry

C. Di Mario, A. Colombo, T. Münzel, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Optical coherence tomography tissue coverage and characterization at six months after implantation of bioresorbable scaffolds versus conventional everolimus eluting stents in the ISAR-Absorb MI trial

M. Joner, A. Kastrati, R. Colleran, 2021, The International Journal of Cardiovascular Imaging.

Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).

Petr Neuzil, Jens Wiebe, P. Neužil, 2013, Journal of the American College of Cardiology.

Safety of percutaneous left atrial appendage closure with the amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation

S. Bertog, J. Franke, H. Sievert, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Percutaneous Left Atrial Appendage Closure With the Watchman Device: Long-Term Results Up to 5 Years.

S. Bertog, J. Franke, H. Sievert, 2015, JACC. Cardiovascular interventions.

SARS-CoV-2 Infection in Asymptomatic Patients Hospitalized for Cardiac Emergencies: Implications for Patient Management

H. Schunkert, A. Kastrati, T. Kessler, 2020, Frontiers in Cardiovascular Medicine.

Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials

Heribert Schunkert, Adnan Kastrati, Takeshi Kimura, 2016, The Lancet.

Evaluation of the short- and long-term safety and therapy outcomes of the everolimus-eluting bioresorbable vascular scaffold system in patients with coronary artery stenosis: Rationale and design of the German-Austrian ABSORB RegIstRy (GABI-R).

S. Achenbach, A. Schmermund, J. Mehilli, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry.

Antonio Colombo, Tommaso Gori, Salvatore Geraci, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation

P. Neužil, G. Schuler, V. Reddy, 2013 .

Influence of Renal Sympathetic Denervation on Cardiac Extracellular Matrix Turnover and Cardiac Fibrosis.

C. Hamm, C. Liebetrau, L. Gaede, 2015, American journal of hypertension.

Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension

C. Hamm, F. Mahfoud, C. Liebetrau, 2015, Clinical Research in Cardiology.

Intraindividual Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Drug-Eluting Metallic Stents

H. Schunkert, A. Kastrati, Y. Harada, 2016, Circulation. Cardiovascular interventions.

Long‐term verification of functional and structural renal damage after renal sympathetic denervation

M. Renker, C. Hamm, C. Liebetrau, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Ten-year clinical outcomes of polymer-free versus durable polymer new-generation drug-eluting stent in patients with coronary artery disease with and without diabetes mellitus

H. Schunkert, M. Joner, A. Kastrati, 2021, Clinical Research in Cardiology.

Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis

H. Schunkert, M. Joner, A. Kastrati, 2017, JAMA cardiology.

TCT-207 Extended validation of a decision tool (DAPT score) in patients randomized to 6 or 12 months dual antiplatelet therapy after percutaneous coronary intervention with predominantly second-generation drug-eluting stents.

A. Kastrati, Y. Harada, J. Michel, 2016, Journal of the American College of Cardiology.

Outcomes of rotational atherectomy versus modified balloon angioplasty in severely calcified coronary lesions based on target lesion location: a post hoc analysis of the PREPARE-CALC randomised trial

A. Kastrati, R. Byrne, G. Richardt, 2020 .

Derivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosis.

H. Schunkert, M. Joner, A. Kastrati, 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Prognostic value of glomerular function estimated by Cockcroft-Gault creatinine clearance, MDRD-4, CKD-EPI and European Kidney Function Consortium equations in patients with acute coronary syndromes.

H. Schunkert, M. Joner, A. Kastrati, 2021, Clinica chimica acta; international journal of clinical chemistry.

Ten‐Year Clinical Outcomes of Biodegradable Versus Durable Polymer New‐Generation Drug‐Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus

H. Schunkert, M. Joner, A. Kastrati, 2021, Journal of the American Heart Association.

Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.

H. Schunkert, M. Joner, A. Kastrati, 2023, European heart journal.

Ten-year clinical outcomes of drug-eluting stents with different polymer coating strategies by degree of coronary calcification: a pooled analysis of the ISAR-TEST 4 and 5 randomised trials.

H. Schunkert, M. Joner, A. Kastrati, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold

S. Achenbach, C. Hamm, C. Liebetrau, 2014, Clinical Research in Cardiology.

Outcomes after complete dissolution of everolimus-eluting bioresorbable scaffolds implanted during routine practice.

H. Schunkert, M. Joner, A. Kastrati, 2020, Revista espanola de cardiologia.

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score.

J. Mehilli, C. Di Mario, A. Colombo, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

10-Year Outcomes From a Randomized Trial of Polymer-Free Versus Durable Polymer Drug-Eluting Coronary Stents.

H. Schunkert, M. Joner, A. Kastrati, 2020, Journal of the American College of Cardiology.

Randomized Trial of Polymer-Free Sirolimus- and Probucol-Eluting Stents Versus Durable Polymer Zotarolimus-Eluting Stents: 5-Year Results of the ISAR-TEST-5 Trial.

A. Kastrati, J. Mehilli, Raphaela Lohaus, 2016, JACC. Cardiovascular interventions.

Left Atrial Appendage Closure in Patients With Contraindications to Oral Anticoagulation.

P. Neužil, V. Reddy, S. Möbius‐Winkler, 2016, Journal of the American College of Cardiology.

Overlapping implantation of bioresorbable novolimus-eluting scaffolds: an observational optical coherence tomography study

S. Achenbach, C. Hamm, C. Schlundt, 2017, Heart and Vessels.

Outcome After Long-segment Stenting With Everolimus-eluting Bioresorbable Scaffolds Focusing on the Concept of Overlapping Implantation.

C. Hamm, C. Liebetrau, H. Möllmann, 2016, Revista espanola de cardiologia.

Feasibility of everolimus-eluting bioresorbable vascular scaffolds in patients with chronic total occlusion.

C. Hamm, C. Liebetrau, H. Möllmann, 2015, International journal of cardiology.

Long‐term clinical outcomes after drug eluting stent implantation with and without stent overlap

H. Schunkert, M. Joner, A. Kastrati, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of overlapping on 1‐year clinical outcomes in patients undergoing everolimus‐eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST‐EU registry

J. Mehilli, C. Di Mario, A. Colombo, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Implantation of everolimus‐eluting bioresorbable scaffolds in a diabetic all‐comers population

C. Hamm, C. Liebetrau, H. Möllmann, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

First Formal Analysis of the “ASA Plavix Registry” (ASAP): Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients With Contradication to Oral Anticoagulation

P. Neužil, G. Schuler, V. Reddy, 2012 .

A multicenter post‐marketing evaluation of the Elixir DESolve® Novolimus‐eluting bioresorbable coronary scaffold system: First results from the DESolve PMCF study

A. Colombo, K. Hauptmann, C. Hamm, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Optical coherence tomography tissue coverage and characterization with grey-scale signal intensity analysis after bifurcation stenting with a new generation bioabsorbable polymer drug-eluting stent.

M. Joner, A. Kastrati, D. Foley, 2020, Cardiovascular Revascularization Medicine.

Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016 .

Impact of target lesion location on procedural and angiographic outcomes of rotational atherectomy versus modified balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions:a subgroup analysis of the PREPARE-CALC randomized trial.

A. Kastrati, R. Byrne, G. Richardt, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

INFLUENCE OF RENAL SYMPATHETIC DENERVATION ON VASCULAR INFLAMMATION IN ESSENTIAL HYPERTENSION

C. Hamm, C. Liebetrau, L. Gaede, 2014 .

Ten‐year outcomes after percutaneous coronary intervention of in‐stent restenosis in saphenous vein grafts

A. Kastrati, S. Kufner, T. Ibrahim, 2023, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

P. Neužil, G. Schuler, V. Reddy, 2013, Journal of the American College of Cardiology.

TCT-12 Impact of overlap on long-term clinical outcomes in patients undergoing everolimus-eluting bioresorbable vascular scaffolds implantation in routine clinical practice: insights from the European multicenter GHOST-EU registry

J. Mehilli, A. Colombo, S. Brugaletta, 2015 .

Early Aspirin Discontinuation After Coronary Stenting: A Systematic Review and Meta‐Analysis

M. Joner, A. Kastrati, G. Ndrepepa, 2021, Journal of the American Heart Association.

ON LEFT ATRIAL APPENDAGE CLOSURE STRUCTURAL Percutaneous Left Atrial Appendage Closure With the Watchman Device Long-Term Results Up to 5 Years

S. Bertog, J. Franke, H. Sievert, 2015 .

Very long-term outlook of acute coronary syndromes after percutaneous coronary intervention with implantation of polymer-free versus durable-polymer new-generation drug-eluting stents.

H. Schunkert, M. Joner, A. Kastrati, 2023, Minerva medica.